Global Biofunctional Peptide Market
Global Biofunctional Peptide Market

Biofunctional Peptide Comprehensive Study by Application (Anti-Hypertensive, Cardiovascular System, Nervous System, Gastrointestinal System, Immune System, Cholesterol-Lowering, Anti-Diabetic Peptides, Multifunctional Peptides), Processing Method (Enzymatic Hydrolysis, Microbial Fermentation, Recombinant DNA, Chemical Synthesis), Distribution Channel (B2B, B2C (Online, Drug Store, Specialty Store, Mail Order Pharmacy, Hospital Pharmacy, Others)), Source (Animal, Vegetal) Players and Region - Global Market Outlook to 2026

Biofunctional Peptide Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Jul 2021 Edition 231 Pages 217 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Biofunctional Peptide Market Scope?
Biofunctional peptides are specific protein fragments that have a positive impact on body functions and conditions and may ultimately influence health peptides modulate physiological function through binding interactions to specific receptors on target cells leading to the induction of physiological responses. Biofunctional peptides are generally 3-20 amino acids residues in length containing potential bioactive sequences from animal and plant source. The most common method of production for Biofunctional peptides is enzymatic hydrolysis. Multiple Biofunctional peptides are produced using trypsin or pepsin. These Biofunctional peptides play an important role in the regulation of the digestive system, immune system, cardiovascular, nervous system and modulation of nutrient absorption. Currently, the market products of Biofunctional peptides contain peptides with satiety including anti-cancer, antimicrobial, stress-relieving properties and others. Biofunctional peptides possess a scientific challenge as they are known to cause optimal exploitation for health benefits. At the same time Biofunctional peptides offer various commercial benefits, owing to which the market of Biofunctional peptides is anticipated to have rapid growth with exceptional CAGR over the forecast period.

The Biofunctional Peptide market study is being classified, by Application (Anti-Hypertensive, Cardiovascular System, Nervous System, Gastrointestinal System, Immune System, Cholesterol-Lowering, Anti-Diabetic Peptides and Multifunctional Peptides) and major geographies with country level break-up.

The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analysts at AMA predicts that Vendors from European and United States will contribute to the maximum growth of Global Biofunctional Peptide market throughout the predicted period.

Merck KGaA (Germany), Seagarden AS (Norway), WN Pharmaceuticals Ltd. (Canada), Arlak Biotech Pvt. Ltd. (India), Phermpep Co. Ltd. (Taiwan), Ashland Inc. (United States), ALEXIS Corporation (United States), American Peptide Company Inc. (United States), Promega Corporation (United States), Advanced Bioconcept Company (Canada), Anaspec Inc. (United States), Thermo Fisher Scientific (United States) and Novo Nordisk A/S (Denmark) are some of the key players profiled in the study.

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Biofunctional Peptide market by Type, Application and Region.

On the basis of geography, the market of Biofunctional Peptide has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).




Influencing Market Trend
  • The Willingness of Consumers in This Age Group to Spend On Premium Quality Personal Care Products
  • Increasing Penetration of E-Commerce for Selling Fast Moving Consumer Goods Products

Market Drivers
  • Awareness Regarding Benefits of Natural or Organic Skincare Products
  • Shifting Of Retailers from Niche Distribution Channels to Mainstream Mass Retailers
  • A Rise in Biofunctional Peptide Use in Products-Such As Creams, Moisturizers, and Anti-Hair Fall Products
  • Rising Popularity among Aging Female Population

Opportunities
  • Consumersí Behavior Has Drastically Changed and Are More Inclined Towards Researching About Products Online and Purchasing Various Products
  • Increasing Consumersí Demand for Green Personal Care Products Has Prompted Companies to Enter the Herbal and Natural Personal Care Products

Restraints
  • High Price Associated With the Products

Challenges
  • Less Awareness among Conventional Players


Key Target Audience
Providers of Biofunctional Peptide, New Entrants and Investors, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Frequently Asked Questions (FAQ):

1. At what growth rate would the Biofunctional Peptide market expands?
The Global Biofunctional Peptide market is expected to see a growth of % during projected year 2020 to 2026.

2. Who are the prominent players of the Global Biofunctional Peptide market?
The prominent players of Global Biofunctional Peptide market are Merck KGaA (Germany), Seagarden AS (Norway), WN Pharmaceuticals Ltd. (Canada), Arlak Biotech Pvt. Ltd. (India), Phermpep Co. Ltd. (Taiwan), Ashland Inc. (United States), ALEXIS Corporation (United States), American Peptide Company Inc. (United States), Promega Corporation (United States), Advanced Bioconcept Company (Canada), Anaspec Inc. (United States), Thermo Fisher Scientific (United States) and Novo Nordisk A/S (Denmark), to name a few.

3. What are the top priorities to focus for Biofunctional Peptide marketís growth?
In this highly competitive & fast evolving Biofunctional Peptide industry, the top strategic priorities would remain consistent like innovation, R&D and M&A.
Report Objectives / Segmentation Covered
By Application
  • Anti-Hypertensive
  • Cardiovascular System
  • Nervous System
  • Gastrointestinal System
  • Immune System
  • Cholesterol-Lowering
  • Anti-Diabetic Peptides
  • Multifunctional Peptides
By Processing Method
  • Enzymatic Hydrolysis
  • Microbial Fermentation
  • Recombinant DNA
  • Chemical Synthesis

By Distribution Channel
  • B2B
  • B2C [Online, Drug Store, Specialty Store, Mail Order Pharmacy, Hospital Pharmacy, Others]

By Source
  • Animal
  • Vegetal

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Awareness Regarding Benefits of Natural or Organic Skincare Products
      • 3.2.2. Shifting Of Retailers from Niche Distribution Channels to Mainstream Mass Retailers
      • 3.2.3. A Rise in Biofunctional Peptide Use in Products-Such As Creams, Moisturizers, and Anti-Hair Fall Products
      • 3.2.4. Rising Popularity among Aging Female Population
    • 3.3. Market Challenges
      • 3.3.1. Less Awareness among Conventional Players
    • 3.4. Market Trends
      • 3.4.1. The Willingness of Consumers in This Age Group to Spend On Premium Quality Personal Care Products
      • 3.4.2. Increasing Penetration of E-Commerce for Selling Fast Moving Consumer Goods Products
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Biofunctional Peptide, by Application, Processing Method, Distribution Channel, Source and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Biofunctional Peptide (Value)
      • 5.2.1. Global Biofunctional Peptide by: Application (Value)
        • 5.2.1.1. Anti-Hypertensive
        • 5.2.1.2. Cardiovascular System
        • 5.2.1.3. Nervous System
        • 5.2.1.4. Gastrointestinal System
        • 5.2.1.5. Immune System
        • 5.2.1.6. Cholesterol-Lowering
        • 5.2.1.7. Anti-Diabetic Peptides
        • 5.2.1.8. Multifunctional Peptides
      • 5.2.2. Global Biofunctional Peptide by: Processing Method (Value)
        • 5.2.2.1. Enzymatic Hydrolysis
        • 5.2.2.2. Microbial Fermentation
        • 5.2.2.3. Recombinant DNA
        • 5.2.2.4. Chemical Synthesis
      • 5.2.3. Global Biofunctional Peptide by: Distribution Channel (Value)
        • 5.2.3.1. B2B
        • 5.2.3.2. B2C [Online, Drug Store, Specialty Store, Mail Order Pharmacy, Hospital Pharmacy, Others]
      • 5.2.4. Global Biofunctional Peptide by: Source (Value)
        • 5.2.4.1. Animal
        • 5.2.4.2. Vegetal
      • 5.2.5. Global Biofunctional Peptide Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Biofunctional Peptide (Price)
  • 6. Biofunctional Peptide: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Merck KGaA (Germany)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Seagarden AS (Norway)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. WN Pharmaceuticals Ltd. (Canada)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Arlak Biotech Pvt. Ltd. (India)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Phermpep Co. Ltd. (Taiwan)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Ashland Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. ALEXIS Corporation (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. American Peptide Company Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Promega Corporation (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Advanced Bioconcept Company (Canada)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Anaspec Inc. (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Thermo Fisher Scientific (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Novo Nordisk A/S (Denmark)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
  • 7. Global Biofunctional Peptide Sale, by Application, Processing Method, Distribution Channel, Source and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Biofunctional Peptide (Value)
      • 7.2.1. Global Biofunctional Peptide by: Application (Value)
        • 7.2.1.1. Anti-Hypertensive
        • 7.2.1.2. Cardiovascular System
        • 7.2.1.3. Nervous System
        • 7.2.1.4. Gastrointestinal System
        • 7.2.1.5. Immune System
        • 7.2.1.6. Cholesterol-Lowering
        • 7.2.1.7. Anti-Diabetic Peptides
        • 7.2.1.8. Multifunctional Peptides
      • 7.2.2. Global Biofunctional Peptide by: Processing Method (Value)
        • 7.2.2.1. Enzymatic Hydrolysis
        • 7.2.2.2. Microbial Fermentation
        • 7.2.2.3. Recombinant DNA
        • 7.2.2.4. Chemical Synthesis
      • 7.2.3. Global Biofunctional Peptide by: Distribution Channel (Value)
        • 7.2.3.1. B2B
        • 7.2.3.2. B2C [Online, Drug Store, Specialty Store, Mail Order Pharmacy, Hospital Pharmacy, Others]
      • 7.2.4. Global Biofunctional Peptide by: Source (Value)
        • 7.2.4.1. Animal
        • 7.2.4.2. Vegetal
      • 7.2.5. Global Biofunctional Peptide Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Biofunctional Peptide (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Biofunctional Peptide: by Application(USD Million)
  • Table 2. Biofunctional Peptide Anti-Hypertensive , by Region USD Million (2015-2020)
  • Table 3. Biofunctional Peptide Cardiovascular System , by Region USD Million (2015-2020)
  • Table 4. Biofunctional Peptide Nervous System , by Region USD Million (2015-2020)
  • Table 5. Biofunctional Peptide Gastrointestinal System , by Region USD Million (2015-2020)
  • Table 6. Biofunctional Peptide Immune System , by Region USD Million (2015-2020)
  • Table 7. Biofunctional Peptide Cholesterol-Lowering , by Region USD Million (2015-2020)
  • Table 8. Biofunctional Peptide Anti-Diabetic Peptides , by Region USD Million (2015-2020)
  • Table 9. Biofunctional Peptide Multifunctional Peptides , by Region USD Million (2015-2020)
  • Table 10. Biofunctional Peptide: by Processing Method(USD Million)
  • Table 11. Biofunctional Peptide Enzymatic Hydrolysis , by Region USD Million (2015-2020)
  • Table 12. Biofunctional Peptide Microbial Fermentation , by Region USD Million (2015-2020)
  • Table 13. Biofunctional Peptide Recombinant DNA , by Region USD Million (2015-2020)
  • Table 14. Biofunctional Peptide Chemical Synthesis , by Region USD Million (2015-2020)
  • Table 15. Biofunctional Peptide: by Distribution Channel(USD Million)
  • Table 16. Biofunctional Peptide B2B , by Region USD Million (2015-2020)
  • Table 17. Biofunctional Peptide B2C [Online, Drug Store, Specialty Store, Mail Order Pharmacy, Hospital Pharmacy, Others] , by Region USD Million (2015-2020)
  • Table 18. Biofunctional Peptide: by Source(USD Million)
  • Table 19. Biofunctional Peptide Animal , by Region USD Million (2015-2020)
  • Table 20. Biofunctional Peptide Vegetal , by Region USD Million (2015-2020)
  • Table 21. South America Biofunctional Peptide, by Country USD Million (2015-2020)
  • Table 22. South America Biofunctional Peptide, by Application USD Million (2015-2020)
  • Table 23. South America Biofunctional Peptide, by Processing Method USD Million (2015-2020)
  • Table 24. South America Biofunctional Peptide, by Distribution Channel USD Million (2015-2020)
  • Table 25. South America Biofunctional Peptide, by Source USD Million (2015-2020)
  • Table 26. Brazil Biofunctional Peptide, by Application USD Million (2015-2020)
  • Table 27. Brazil Biofunctional Peptide, by Processing Method USD Million (2015-2020)
  • Table 28. Brazil Biofunctional Peptide, by Distribution Channel USD Million (2015-2020)
  • Table 29. Brazil Biofunctional Peptide, by Source USD Million (2015-2020)
  • Table 30. Argentina Biofunctional Peptide, by Application USD Million (2015-2020)
  • Table 31. Argentina Biofunctional Peptide, by Processing Method USD Million (2015-2020)
  • Table 32. Argentina Biofunctional Peptide, by Distribution Channel USD Million (2015-2020)
  • Table 33. Argentina Biofunctional Peptide, by Source USD Million (2015-2020)
  • Table 34. Rest of South America Biofunctional Peptide, by Application USD Million (2015-2020)
  • Table 35. Rest of South America Biofunctional Peptide, by Processing Method USD Million (2015-2020)
  • Table 36. Rest of South America Biofunctional Peptide, by Distribution Channel USD Million (2015-2020)
  • Table 37. Rest of South America Biofunctional Peptide, by Source USD Million (2015-2020)
  • Table 38. Asia Pacific Biofunctional Peptide, by Country USD Million (2015-2020)
  • Table 39. Asia Pacific Biofunctional Peptide, by Application USD Million (2015-2020)
  • Table 40. Asia Pacific Biofunctional Peptide, by Processing Method USD Million (2015-2020)
  • Table 41. Asia Pacific Biofunctional Peptide, by Distribution Channel USD Million (2015-2020)
  • Table 42. Asia Pacific Biofunctional Peptide, by Source USD Million (2015-2020)
  • Table 43. China Biofunctional Peptide, by Application USD Million (2015-2020)
  • Table 44. China Biofunctional Peptide, by Processing Method USD Million (2015-2020)
  • Table 45. China Biofunctional Peptide, by Distribution Channel USD Million (2015-2020)
  • Table 46. China Biofunctional Peptide, by Source USD Million (2015-2020)
  • Table 47. Japan Biofunctional Peptide, by Application USD Million (2015-2020)
  • Table 48. Japan Biofunctional Peptide, by Processing Method USD Million (2015-2020)
  • Table 49. Japan Biofunctional Peptide, by Distribution Channel USD Million (2015-2020)
  • Table 50. Japan Biofunctional Peptide, by Source USD Million (2015-2020)
  • Table 51. India Biofunctional Peptide, by Application USD Million (2015-2020)
  • Table 52. India Biofunctional Peptide, by Processing Method USD Million (2015-2020)
  • Table 53. India Biofunctional Peptide, by Distribution Channel USD Million (2015-2020)
  • Table 54. India Biofunctional Peptide, by Source USD Million (2015-2020)
  • Table 55. South Korea Biofunctional Peptide, by Application USD Million (2015-2020)
  • Table 56. South Korea Biofunctional Peptide, by Processing Method USD Million (2015-2020)
  • Table 57. South Korea Biofunctional Peptide, by Distribution Channel USD Million (2015-2020)
  • Table 58. South Korea Biofunctional Peptide, by Source USD Million (2015-2020)
  • Table 59. Taiwan Biofunctional Peptide, by Application USD Million (2015-2020)
  • Table 60. Taiwan Biofunctional Peptide, by Processing Method USD Million (2015-2020)
  • Table 61. Taiwan Biofunctional Peptide, by Distribution Channel USD Million (2015-2020)
  • Table 62. Taiwan Biofunctional Peptide, by Source USD Million (2015-2020)
  • Table 63. Australia Biofunctional Peptide, by Application USD Million (2015-2020)
  • Table 64. Australia Biofunctional Peptide, by Processing Method USD Million (2015-2020)
  • Table 65. Australia Biofunctional Peptide, by Distribution Channel USD Million (2015-2020)
  • Table 66. Australia Biofunctional Peptide, by Source USD Million (2015-2020)
  • Table 67. Rest of Asia-Pacific Biofunctional Peptide, by Application USD Million (2015-2020)
  • Table 68. Rest of Asia-Pacific Biofunctional Peptide, by Processing Method USD Million (2015-2020)
  • Table 69. Rest of Asia-Pacific Biofunctional Peptide, by Distribution Channel USD Million (2015-2020)
  • Table 70. Rest of Asia-Pacific Biofunctional Peptide, by Source USD Million (2015-2020)
  • Table 71. Europe Biofunctional Peptide, by Country USD Million (2015-2020)
  • Table 72. Europe Biofunctional Peptide, by Application USD Million (2015-2020)
  • Table 73. Europe Biofunctional Peptide, by Processing Method USD Million (2015-2020)
  • Table 74. Europe Biofunctional Peptide, by Distribution Channel USD Million (2015-2020)
  • Table 75. Europe Biofunctional Peptide, by Source USD Million (2015-2020)
  • Table 76. Germany Biofunctional Peptide, by Application USD Million (2015-2020)
  • Table 77. Germany Biofunctional Peptide, by Processing Method USD Million (2015-2020)
  • Table 78. Germany Biofunctional Peptide, by Distribution Channel USD Million (2015-2020)
  • Table 79. Germany Biofunctional Peptide, by Source USD Million (2015-2020)
  • Table 80. France Biofunctional Peptide, by Application USD Million (2015-2020)
  • Table 81. France Biofunctional Peptide, by Processing Method USD Million (2015-2020)
  • Table 82. France Biofunctional Peptide, by Distribution Channel USD Million (2015-2020)
  • Table 83. France Biofunctional Peptide, by Source USD Million (2015-2020)
  • Table 84. Italy Biofunctional Peptide, by Application USD Million (2015-2020)
  • Table 85. Italy Biofunctional Peptide, by Processing Method USD Million (2015-2020)
  • Table 86. Italy Biofunctional Peptide, by Distribution Channel USD Million (2015-2020)
  • Table 87. Italy Biofunctional Peptide, by Source USD Million (2015-2020)
  • Table 88. United Kingdom Biofunctional Peptide, by Application USD Million (2015-2020)
  • Table 89. United Kingdom Biofunctional Peptide, by Processing Method USD Million (2015-2020)
  • Table 90. United Kingdom Biofunctional Peptide, by Distribution Channel USD Million (2015-2020)
  • Table 91. United Kingdom Biofunctional Peptide, by Source USD Million (2015-2020)
  • Table 92. Netherlands Biofunctional Peptide, by Application USD Million (2015-2020)
  • Table 93. Netherlands Biofunctional Peptide, by Processing Method USD Million (2015-2020)
  • Table 94. Netherlands Biofunctional Peptide, by Distribution Channel USD Million (2015-2020)
  • Table 95. Netherlands Biofunctional Peptide, by Source USD Million (2015-2020)
  • Table 96. Rest of Europe Biofunctional Peptide, by Application USD Million (2015-2020)
  • Table 97. Rest of Europe Biofunctional Peptide, by Processing Method USD Million (2015-2020)
  • Table 98. Rest of Europe Biofunctional Peptide, by Distribution Channel USD Million (2015-2020)
  • Table 99. Rest of Europe Biofunctional Peptide, by Source USD Million (2015-2020)
  • Table 100. MEA Biofunctional Peptide, by Country USD Million (2015-2020)
  • Table 101. MEA Biofunctional Peptide, by Application USD Million (2015-2020)
  • Table 102. MEA Biofunctional Peptide, by Processing Method USD Million (2015-2020)
  • Table 103. MEA Biofunctional Peptide, by Distribution Channel USD Million (2015-2020)
  • Table 104. MEA Biofunctional Peptide, by Source USD Million (2015-2020)
  • Table 105. Middle East Biofunctional Peptide, by Application USD Million (2015-2020)
  • Table 106. Middle East Biofunctional Peptide, by Processing Method USD Million (2015-2020)
  • Table 107. Middle East Biofunctional Peptide, by Distribution Channel USD Million (2015-2020)
  • Table 108. Middle East Biofunctional Peptide, by Source USD Million (2015-2020)
  • Table 109. Africa Biofunctional Peptide, by Application USD Million (2015-2020)
  • Table 110. Africa Biofunctional Peptide, by Processing Method USD Million (2015-2020)
  • Table 111. Africa Biofunctional Peptide, by Distribution Channel USD Million (2015-2020)
  • Table 112. Africa Biofunctional Peptide, by Source USD Million (2015-2020)
  • Table 113. North America Biofunctional Peptide, by Country USD Million (2015-2020)
  • Table 114. North America Biofunctional Peptide, by Application USD Million (2015-2020)
  • Table 115. North America Biofunctional Peptide, by Processing Method USD Million (2015-2020)
  • Table 116. North America Biofunctional Peptide, by Distribution Channel USD Million (2015-2020)
  • Table 117. North America Biofunctional Peptide, by Source USD Million (2015-2020)
  • Table 118. United States Biofunctional Peptide, by Application USD Million (2015-2020)
  • Table 119. United States Biofunctional Peptide, by Processing Method USD Million (2015-2020)
  • Table 120. United States Biofunctional Peptide, by Distribution Channel USD Million (2015-2020)
  • Table 121. United States Biofunctional Peptide, by Source USD Million (2015-2020)
  • Table 122. Canada Biofunctional Peptide, by Application USD Million (2015-2020)
  • Table 123. Canada Biofunctional Peptide, by Processing Method USD Million (2015-2020)
  • Table 124. Canada Biofunctional Peptide, by Distribution Channel USD Million (2015-2020)
  • Table 125. Canada Biofunctional Peptide, by Source USD Million (2015-2020)
  • Table 126. Mexico Biofunctional Peptide, by Application USD Million (2015-2020)
  • Table 127. Mexico Biofunctional Peptide, by Processing Method USD Million (2015-2020)
  • Table 128. Mexico Biofunctional Peptide, by Distribution Channel USD Million (2015-2020)
  • Table 129. Mexico Biofunctional Peptide, by Source USD Million (2015-2020)
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Biofunctional Peptide: by Application(USD Million)
  • Table 144. Biofunctional Peptide Anti-Hypertensive , by Region USD Million (2021-2026)
  • Table 145. Biofunctional Peptide Cardiovascular System , by Region USD Million (2021-2026)
  • Table 146. Biofunctional Peptide Nervous System , by Region USD Million (2021-2026)
  • Table 147. Biofunctional Peptide Gastrointestinal System , by Region USD Million (2021-2026)
  • Table 148. Biofunctional Peptide Immune System , by Region USD Million (2021-2026)
  • Table 149. Biofunctional Peptide Cholesterol-Lowering , by Region USD Million (2021-2026)
  • Table 150. Biofunctional Peptide Anti-Diabetic Peptides , by Region USD Million (2021-2026)
  • Table 151. Biofunctional Peptide Multifunctional Peptides , by Region USD Million (2021-2026)
  • Table 152. Biofunctional Peptide: by Processing Method(USD Million)
  • Table 153. Biofunctional Peptide Enzymatic Hydrolysis , by Region USD Million (2021-2026)
  • Table 154. Biofunctional Peptide Microbial Fermentation , by Region USD Million (2021-2026)
  • Table 155. Biofunctional Peptide Recombinant DNA , by Region USD Million (2021-2026)
  • Table 156. Biofunctional Peptide Chemical Synthesis , by Region USD Million (2021-2026)
  • Table 157. Biofunctional Peptide: by Distribution Channel(USD Million)
  • Table 158. Biofunctional Peptide B2B , by Region USD Million (2021-2026)
  • Table 159. Biofunctional Peptide B2C [Online, Drug Store, Specialty Store, Mail Order Pharmacy, Hospital Pharmacy, Others] , by Region USD Million (2021-2026)
  • Table 160. Biofunctional Peptide: by Source(USD Million)
  • Table 161. Biofunctional Peptide Animal , by Region USD Million (2021-2026)
  • Table 162. Biofunctional Peptide Vegetal , by Region USD Million (2021-2026)
  • Table 163. South America Biofunctional Peptide, by Country USD Million (2021-2026)
  • Table 164. South America Biofunctional Peptide, by Application USD Million (2021-2026)
  • Table 165. South America Biofunctional Peptide, by Processing Method USD Million (2021-2026)
  • Table 166. South America Biofunctional Peptide, by Distribution Channel USD Million (2021-2026)
  • Table 167. South America Biofunctional Peptide, by Source USD Million (2021-2026)
  • Table 168. Brazil Biofunctional Peptide, by Application USD Million (2021-2026)
  • Table 169. Brazil Biofunctional Peptide, by Processing Method USD Million (2021-2026)
  • Table 170. Brazil Biofunctional Peptide, by Distribution Channel USD Million (2021-2026)
  • Table 171. Brazil Biofunctional Peptide, by Source USD Million (2021-2026)
  • Table 172. Argentina Biofunctional Peptide, by Application USD Million (2021-2026)
  • Table 173. Argentina Biofunctional Peptide, by Processing Method USD Million (2021-2026)
  • Table 174. Argentina Biofunctional Peptide, by Distribution Channel USD Million (2021-2026)
  • Table 175. Argentina Biofunctional Peptide, by Source USD Million (2021-2026)
  • Table 176. Rest of South America Biofunctional Peptide, by Application USD Million (2021-2026)
  • Table 177. Rest of South America Biofunctional Peptide, by Processing Method USD Million (2021-2026)
  • Table 178. Rest of South America Biofunctional Peptide, by Distribution Channel USD Million (2021-2026)
  • Table 179. Rest of South America Biofunctional Peptide, by Source USD Million (2021-2026)
  • Table 180. Asia Pacific Biofunctional Peptide, by Country USD Million (2021-2026)
  • Table 181. Asia Pacific Biofunctional Peptide, by Application USD Million (2021-2026)
  • Table 182. Asia Pacific Biofunctional Peptide, by Processing Method USD Million (2021-2026)
  • Table 183. Asia Pacific Biofunctional Peptide, by Distribution Channel USD Million (2021-2026)
  • Table 184. Asia Pacific Biofunctional Peptide, by Source USD Million (2021-2026)
  • Table 185. China Biofunctional Peptide, by Application USD Million (2021-2026)
  • Table 186. China Biofunctional Peptide, by Processing Method USD Million (2021-2026)
  • Table 187. China Biofunctional Peptide, by Distribution Channel USD Million (2021-2026)
  • Table 188. China Biofunctional Peptide, by Source USD Million (2021-2026)
  • Table 189. Japan Biofunctional Peptide, by Application USD Million (2021-2026)
  • Table 190. Japan Biofunctional Peptide, by Processing Method USD Million (2021-2026)
  • Table 191. Japan Biofunctional Peptide, by Distribution Channel USD Million (2021-2026)
  • Table 192. Japan Biofunctional Peptide, by Source USD Million (2021-2026)
  • Table 193. India Biofunctional Peptide, by Application USD Million (2021-2026)
  • Table 194. India Biofunctional Peptide, by Processing Method USD Million (2021-2026)
  • Table 195. India Biofunctional Peptide, by Distribution Channel USD Million (2021-2026)
  • Table 196. India Biofunctional Peptide, by Source USD Million (2021-2026)
  • Table 197. South Korea Biofunctional Peptide, by Application USD Million (2021-2026)
  • Table 198. South Korea Biofunctional Peptide, by Processing Method USD Million (2021-2026)
  • Table 199. South Korea Biofunctional Peptide, by Distribution Channel USD Million (2021-2026)
  • Table 200. South Korea Biofunctional Peptide, by Source USD Million (2021-2026)
  • Table 201. Taiwan Biofunctional Peptide, by Application USD Million (2021-2026)
  • Table 202. Taiwan Biofunctional Peptide, by Processing Method USD Million (2021-2026)
  • Table 203. Taiwan Biofunctional Peptide, by Distribution Channel USD Million (2021-2026)
  • Table 204. Taiwan Biofunctional Peptide, by Source USD Million (2021-2026)
  • Table 205. Australia Biofunctional Peptide, by Application USD Million (2021-2026)
  • Table 206. Australia Biofunctional Peptide, by Processing Method USD Million (2021-2026)
  • Table 207. Australia Biofunctional Peptide, by Distribution Channel USD Million (2021-2026)
  • Table 208. Australia Biofunctional Peptide, by Source USD Million (2021-2026)
  • Table 209. Rest of Asia-Pacific Biofunctional Peptide, by Application USD Million (2021-2026)
  • Table 210. Rest of Asia-Pacific Biofunctional Peptide, by Processing Method USD Million (2021-2026)
  • Table 211. Rest of Asia-Pacific Biofunctional Peptide, by Distribution Channel USD Million (2021-2026)
  • Table 212. Rest of Asia-Pacific Biofunctional Peptide, by Source USD Million (2021-2026)
  • Table 213. Europe Biofunctional Peptide, by Country USD Million (2021-2026)
  • Table 214. Europe Biofunctional Peptide, by Application USD Million (2021-2026)
  • Table 215. Europe Biofunctional Peptide, by Processing Method USD Million (2021-2026)
  • Table 216. Europe Biofunctional Peptide, by Distribution Channel USD Million (2021-2026)
  • Table 217. Europe Biofunctional Peptide, by Source USD Million (2021-2026)
  • Table 218. Germany Biofunctional Peptide, by Application USD Million (2021-2026)
  • Table 219. Germany Biofunctional Peptide, by Processing Method USD Million (2021-2026)
  • Table 220. Germany Biofunctional Peptide, by Distribution Channel USD Million (2021-2026)
  • Table 221. Germany Biofunctional Peptide, by Source USD Million (2021-2026)
  • Table 222. France Biofunctional Peptide, by Application USD Million (2021-2026)
  • Table 223. France Biofunctional Peptide, by Processing Method USD Million (2021-2026)
  • Table 224. France Biofunctional Peptide, by Distribution Channel USD Million (2021-2026)
  • Table 225. France Biofunctional Peptide, by Source USD Million (2021-2026)
  • Table 226. Italy Biofunctional Peptide, by Application USD Million (2021-2026)
  • Table 227. Italy Biofunctional Peptide, by Processing Method USD Million (2021-2026)
  • Table 228. Italy Biofunctional Peptide, by Distribution Channel USD Million (2021-2026)
  • Table 229. Italy Biofunctional Peptide, by Source USD Million (2021-2026)
  • Table 230. United Kingdom Biofunctional Peptide, by Application USD Million (2021-2026)
  • Table 231. United Kingdom Biofunctional Peptide, by Processing Method USD Million (2021-2026)
  • Table 232. United Kingdom Biofunctional Peptide, by Distribution Channel USD Million (2021-2026)
  • Table 233. United Kingdom Biofunctional Peptide, by Source USD Million (2021-2026)
  • Table 234. Netherlands Biofunctional Peptide, by Application USD Million (2021-2026)
  • Table 235. Netherlands Biofunctional Peptide, by Processing Method USD Million (2021-2026)
  • Table 236. Netherlands Biofunctional Peptide, by Distribution Channel USD Million (2021-2026)
  • Table 237. Netherlands Biofunctional Peptide, by Source USD Million (2021-2026)
  • Table 238. Rest of Europe Biofunctional Peptide, by Application USD Million (2021-2026)
  • Table 239. Rest of Europe Biofunctional Peptide, by Processing Method USD Million (2021-2026)
  • Table 240. Rest of Europe Biofunctional Peptide, by Distribution Channel USD Million (2021-2026)
  • Table 241. Rest of Europe Biofunctional Peptide, by Source USD Million (2021-2026)
  • Table 242. MEA Biofunctional Peptide, by Country USD Million (2021-2026)
  • Table 243. MEA Biofunctional Peptide, by Application USD Million (2021-2026)
  • Table 244. MEA Biofunctional Peptide, by Processing Method USD Million (2021-2026)
  • Table 245. MEA Biofunctional Peptide, by Distribution Channel USD Million (2021-2026)
  • Table 246. MEA Biofunctional Peptide, by Source USD Million (2021-2026)
  • Table 247. Middle East Biofunctional Peptide, by Application USD Million (2021-2026)
  • Table 248. Middle East Biofunctional Peptide, by Processing Method USD Million (2021-2026)
  • Table 249. Middle East Biofunctional Peptide, by Distribution Channel USD Million (2021-2026)
  • Table 250. Middle East Biofunctional Peptide, by Source USD Million (2021-2026)
  • Table 251. Africa Biofunctional Peptide, by Application USD Million (2021-2026)
  • Table 252. Africa Biofunctional Peptide, by Processing Method USD Million (2021-2026)
  • Table 253. Africa Biofunctional Peptide, by Distribution Channel USD Million (2021-2026)
  • Table 254. Africa Biofunctional Peptide, by Source USD Million (2021-2026)
  • Table 255. North America Biofunctional Peptide, by Country USD Million (2021-2026)
  • Table 256. North America Biofunctional Peptide, by Application USD Million (2021-2026)
  • Table 257. North America Biofunctional Peptide, by Processing Method USD Million (2021-2026)
  • Table 258. North America Biofunctional Peptide, by Distribution Channel USD Million (2021-2026)
  • Table 259. North America Biofunctional Peptide, by Source USD Million (2021-2026)
  • Table 260. United States Biofunctional Peptide, by Application USD Million (2021-2026)
  • Table 261. United States Biofunctional Peptide, by Processing Method USD Million (2021-2026)
  • Table 262. United States Biofunctional Peptide, by Distribution Channel USD Million (2021-2026)
  • Table 263. United States Biofunctional Peptide, by Source USD Million (2021-2026)
  • Table 264. Canada Biofunctional Peptide, by Application USD Million (2021-2026)
  • Table 265. Canada Biofunctional Peptide, by Processing Method USD Million (2021-2026)
  • Table 266. Canada Biofunctional Peptide, by Distribution Channel USD Million (2021-2026)
  • Table 267. Canada Biofunctional Peptide, by Source USD Million (2021-2026)
  • Table 268. Mexico Biofunctional Peptide, by Application USD Million (2021-2026)
  • Table 269. Mexico Biofunctional Peptide, by Processing Method USD Million (2021-2026)
  • Table 270. Mexico Biofunctional Peptide, by Distribution Channel USD Million (2021-2026)
  • Table 271. Mexico Biofunctional Peptide, by Source USD Million (2021-2026)
  • Table 272. Research Programs/Design for This Report
  • Table 273. Key Data Information from Secondary Sources
  • Table 274. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Biofunctional Peptide: by Application USD Million (2015-2020)
  • Figure 5. Global Biofunctional Peptide: by Processing Method USD Million (2015-2020)
  • Figure 6. Global Biofunctional Peptide: by Distribution Channel USD Million (2015-2020)
  • Figure 7. Global Biofunctional Peptide: by Source USD Million (2015-2020)
  • Figure 8. South America Biofunctional Peptide Share (%), by Country
  • Figure 9. Asia Pacific Biofunctional Peptide Share (%), by Country
  • Figure 10. Europe Biofunctional Peptide Share (%), by Country
  • Figure 11. MEA Biofunctional Peptide Share (%), by Country
  • Figure 12. North America Biofunctional Peptide Share (%), by Country
  • Figure 13. Global Biofunctional Peptide share by Players 2020 (%)
  • Figure 14. Global Biofunctional Peptide share by Players (Top 3) 2020(%)
  • Figure 15. Global Biofunctional Peptide share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Merck KGaA (Germany) Revenue, Net Income and Gross profit
  • Figure 18. Merck KGaA (Germany) Revenue: by Geography 2020
  • Figure 19. Seagarden AS (Norway) Revenue, Net Income and Gross profit
  • Figure 20. Seagarden AS (Norway) Revenue: by Geography 2020
  • Figure 21. WN Pharmaceuticals Ltd. (Canada) Revenue, Net Income and Gross profit
  • Figure 22. WN Pharmaceuticals Ltd. (Canada) Revenue: by Geography 2020
  • Figure 23. Arlak Biotech Pvt. Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 24. Arlak Biotech Pvt. Ltd. (India) Revenue: by Geography 2020
  • Figure 25. Phermpep Co. Ltd. (Taiwan) Revenue, Net Income and Gross profit
  • Figure 26. Phermpep Co. Ltd. (Taiwan) Revenue: by Geography 2020
  • Figure 27. Ashland Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Ashland Inc. (United States) Revenue: by Geography 2020
  • Figure 29. ALEXIS Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 30. ALEXIS Corporation (United States) Revenue: by Geography 2020
  • Figure 31. American Peptide Company Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. American Peptide Company Inc. (United States) Revenue: by Geography 2020
  • Figure 33. Promega Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 34. Promega Corporation (United States) Revenue: by Geography 2020
  • Figure 35. Advanced Bioconcept Company (Canada) Revenue, Net Income and Gross profit
  • Figure 36. Advanced Bioconcept Company (Canada) Revenue: by Geography 2020
  • Figure 37. Anaspec Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 38. Anaspec Inc. (United States) Revenue: by Geography 2020
  • Figure 39. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 40. Thermo Fisher Scientific (United States) Revenue: by Geography 2020
  • Figure 41. Novo Nordisk A/S (Denmark) Revenue, Net Income and Gross profit
  • Figure 42. Novo Nordisk A/S (Denmark) Revenue: by Geography 2020
  • Figure 43. Global Biofunctional Peptide: by Application USD Million (2021-2026)
  • Figure 44. Global Biofunctional Peptide: by Processing Method USD Million (2021-2026)
  • Figure 45. Global Biofunctional Peptide: by Distribution Channel USD Million (2021-2026)
  • Figure 46. Global Biofunctional Peptide: by Source USD Million (2021-2026)
  • Figure 47. South America Biofunctional Peptide Share (%), by Country
  • Figure 48. Asia Pacific Biofunctional Peptide Share (%), by Country
  • Figure 49. Europe Biofunctional Peptide Share (%), by Country
  • Figure 50. MEA Biofunctional Peptide Share (%), by Country
  • Figure 51. North America Biofunctional Peptide Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Merck KGaA (Germany)
  • Seagarden AS (Norway)
  • WN Pharmaceuticals Ltd. (Canada)
  • Arlak Biotech Pvt. Ltd. (India)
  • Phermpep Co. Ltd. (Taiwan)
  • Ashland Inc. (United States)
  • ALEXIS Corporation (United States)
  • American Peptide Company Inc. (United States)
  • Promega Corporation (United States)
  • Advanced Bioconcept Company (Canada)
  • Anaspec Inc. (United States)
  • Thermo Fisher Scientific (United States)
  • Novo Nordisk A/S (Denmark)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation